KCP Statement on the Final 2022 ESRD Payment Rule
The CMS ESRD proposals are important steps forward to begin to address the health and access inequities that individuals who depend on dialysis care have faced in our health care system. KCP appreciates the ongoing flexibilities CMS has provided in the ESRD quality improvement programs (QIP) as we continue to battle the COVID 19 pandemic, which disproportionately impacts…
CMS Finalizes Kidney Care Demo Changes Targeted At Improving Equity
CMS finalized changes to a mandatory end-stage renal disease payment demonstration focused on using home dialysis and kidney transplants as a way to ease socioeconomic disparities in a final 2022 ESRD payment rule Friday (Oct. 29), and the agency also raised dialysis facilities’ pay rates by more than $2 than it had proposed. Click here…
It’s time to make access to quality kidney care accessible and equitable for all
When COVID-19 first began sweeping through our country last year, it quickly became apparent that minority groups were affected at frighteningly disproportionate rates. According to the CDC, Black Americans more frequently test positive for the coronavirus, have been more likely to be hospitalized with severe illness than White Americans, and die at greater rates. In fact, literature on the pandemic…
Nation’s Largest Kidney Coalition Prioritizes, Advances Key Policies to Promote, Support Home Dialysis Care, Choice, Quality
Kidney Care Partners Advocates for Patient-Centric Home Dialysis Policies with Quality Measure Development; Bipartisan Legislation; and Regulatory Reform to Remove Silos, Promote Innovations WASHINGTON – Kidney Care Partners (KCP) – the nation’s largest kidney care coalition comprised of 35 organizations, including patient advocacy groups, medical and transplant professionals, manufacturers, providers, and researchers dedicated to working…
As financial incentives prove ineffective, kidney community takes steps to improve quality
Quality improvement is a broad term as it applies to health care, and as a major payer for the End-Stage Kidney Disease Program, CMS has tinkered with efforts to influence clinical performance and reduces costs. Most recently, criticism has been leveled at the agency concerning the management of the ESRD Quality Incentive Program (QIP), a…
KCP Statement on July 2021 Proposed ESRD Rule
WASHINGTON – Kidney Care Partners (KCP) – The ESRD rulemaking provides an opportunity to address health disparities among kidney patients – a disproportionate number of whom are minorities – when they reach kidney failure and become beneficiaries of Medicare’s End Stage Renal Disease (ESRD) program, which pays for dialysis care. The kidney community wants to ensure that the…
Kidney Care Quality Alliance to continue developing dialysis facility performance metrics
Initially launched in 2005, Kidney Care Partners is set to re-launch its Kidney Care Quality Alliance through which the organization will continue developing quality measures to improve care for patients receiving dialysis. Click here to read the full article on the Healio Nephrology News & Issues website.
Nations’ Kidney Community Announces Major Initiative to Develop Quality Metrics to Assess Dialysis Provider Performance
Kidney Care Partners, Kidney Care Quality Alliance to Evaluate Measures to Improve Quality, Outcomes WASHINGTON – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers – relaunched the Kidney Care Quality Alliance (KCQA) to develop meaningful measures to evaluate…
Kidney Care Partners Applauds Bipartisan House Members for Re-Introduction of Chronic Kidney Disease Improvement in Research and Treatment Act
WASHINGTON – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers – today commended Congresswoman Terri Sewell (D-AL) and Congressman Vern Buchanan (R-FL) for their re-introduction of the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 4065)….
A bipartisan solution to address chronic kidney disease in America
Our country has faced significant public health challenges over the past year and a half. While in the U.S. the COVID-19 pandemic is beginning to come under control, another under-recognized epidemic has continued unabated. According to the latest statistics from the Centers for Disease Control and Prevention, 37 million Americans — or about 15 percent of the…